Ligand validation:4US3

BNG: nonyl beta-D-glucopyranoside

BNG is a Ligand Of Interest in 4US3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4US3_BNG_A_1449	45%	43%	0.166	0.899	0.98	1.22	2	6	0	0	100%	1
4US3_BNG_A_1451	43%	40%	0.166	0.889	1.01	1.33	2	5	0	0	100%	1
4US3_BNG_A_1450	15%	43%	0.255	0.817	1.03	1.16	2	1	0	0	100%	1
4US3_BNG_A_1458	7%	33%	0.27	0.717	0.96	1.69	1	6	0	0	100%	1
6YU5_BNG_A_504	60%	45%	0.145	0.932	1.31	0.84	2	-	3	0	100%	1
6YU7_BNG_A_507	39%	48%	0.183	0.891	1.24	0.79	2	-	2	0	100%	1
4RP9_BNG_A_503	84%	70%	0.091	0.952	0.38	0.76	-	-	3	0	100%	1
4DVE_BNG_B_202	81%	66%	0.092	0.945	0.47	0.83	-	1	0	0	100%	0.5
5B0W_BNG_F_304	74%	49%	0.088	0.917	1.25	0.73	3	-	2	0	100%	1
4MES_BNG_B_201	72%	51%	0.128	0.953	0.83	1.05	-	2	5	0	100%	1
4MUU_BNG_A_202	70%	41%	0.117	0.934	0.85	1.45	-	6	1	0	100%	0.66

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.